Immunis Inc.‘s press release announcing the first-in-human injection of STEM was highlighted by Lifespan.io, an online news source for breakthrough technologies and scientific discoveries in aging and longevity. The article is entitled “Immunis Begins Clinical Trial of Stem Cell Secretome.” The high-level, scientific content for Lifespan.io is supported by The Lifespan Extension Advocacy Foundation (LEAF), a 501(c)(3) non-profit organization promoting fundamental research on aging and age-related diseases, as well as educating the public on the possibility of preventing age-related diseases.